Zydus Gets USFDA Final Nod for Ascorbic Acid Injection, Gains Competitive Generic Therapy Status Written By sheeba farhat21 Aug 2026 12:15 PM ISTAhmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New...
Zydus Receives USFDA EIR with VAI Status for Ahmedabad Injectable Facility Written By MD Bureau3 Aug 2026 7:05 PM ISTNew Delhi: Zydus Lifesciences Limited has announced that it has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug...
DCGI Gives Go-Ahead for Phase III Trial of Zydus' Desidustat in Sickle Cell Disease Written By Susmita Roy25 July 2026 8:17 PM ISTNew Delhi: Zydus Lifesciences Limited (Zydus), an innovation-led global lifesciences company, has received permission to conduct a Phase III clinical...
Delhi HC Restrains Zydus from Receiving Supplies of Cancer Drug Ikra in AbbVie Patent Dispute Written By Susmita Roy14 July 2026 11:50 PM ISTNew Delhi: The Delhi High Court has passed an interim order in a patent infringement dispute between global biopharmaceutical company AbbVie...
Zydus Inks MoU with Apollo Hospitals to Launch Multi-Cancer Blood Test in India Written By MD Bureau4 July 2026 10:38 PM ISTNew Delhi: Zydus Lifesciences Ltd. has entered into an exclusive agreement with precision oncology company Guardant Health to introduce the Shield...
Zydus Lifesciences to Invest Up to Rs 43 Crore in Sri Lanka Pharma Joint Venture Written By Parthika Patel28 Jun 2026 11:00 AM ISTNew Delhi: Zydus Lifesciences Limited has entered into a Share Subscription and Shareholders' Agreement (SSSHA) with Sunshine Healthcare Lanka Limited...
Zydus Completes USD 166.4 Million Acquisition of US-Based Assertio Holdings Written By sheeba farhat17 Jun 2026 9:36 PM ISTNew Delhi: Zydus Lifesciences on Tuesday said it has completed the USD 166.4 million acquisition of US-based pharma company Assertio Holdings Inc.The...
Zydus Wins GST Appeal, Rs 41.9 Lakh Demand Reduced to Rs 0.44 Lakh Written By Parthika Patel14 Jun 2026 6:34 PM ISTAhmedabad: Zydus Lifesciences Limited has informed stock exchanges that its wholly owned subsidiary, Zydus Healthcare Limited (ZHL), has received...
Zydus Under USFDA Lens as Baddi Plant Receives Warning Letter Written By Parthika Patel4 Jun 2026 10:04 PM ISTNew Delhi: Zydus Lifesciences has informed the stock exchanges that it has received a Warning Letter from the United States Food and Drug...
Zydus' Saroglitazar Gets USFDA Priority Review for Rare Liver Disease PBC Written By Parthika Patel29 May 2026 12:00 PM ISTNew Delhi: Zydus Lifesciences has announced that the United States Food and Drug Administration (USFDA) has granted Priority Review to the New Drug...
Sakar Healthcare Signs Oncology Supply Pact with Zydus for GCC, Emerging Markets Written By sheeba farhat25 May 2026 12:30 PM ISTNew Delhi: Drug firm Sakar Healthcare on Thursday said it has signed an agreement with Zydus Lifesciences for the supply of oncology products across...
Zydus Faces Rs 1.18 Crore GST Blow as Appellate Authority Upholds Tax Demand, Penalty Written By Parthika Patel15 May 2026 10:29 PM ISTNew Delhi: Zydus Lifesciences has said that the Appellate Authority of the Central Goods and Services Tax Appeals Commissionerate, Chandigarh, has...
